| Literature DB >> 35454024 |
Sang-Hun Ko1, Kwang-Hwan Jung1, Jae-Ryong Cha1, Ki-Bong Park1.
Abstract
Studies regarding the variables that could predict the success of conservative treatment for knee hemarthrosis are lacking. This retrospective study evaluated the laboratory variables of patients who had unsatisfactory results from conservative treatment for knee hemarthrosis. Twenty-nine patients conservatively treated for knee hemarthrosis were included and divided into two groups: group A comprised 14 patients who underwent interventional angiography and selective embolization due to failed conservative treatment, and group B comprised 15 patients with successful results after conservative treatment. The results of the serological and synovial fluid tests were evaluated. The mean number of synovial red blood cells (RBCs) was 1,905,857 cells/µL and 7730 cells/µL in groups A and B, respectively (p = 0.01), while the mean number of RBCs per high-power field (HPF) was 68.9 and 3.2, respectively (p < 0.01). Patients who underwent interventional angiography and selective embolization after failed conservative treatment for knee hemarthrosis had higher synovial RBC counts and RBC counts per HPF than those with successful outcomes after conservative treatment. It is necessary to carefully interpret the results of the synovial fluid analysis in patients with knee hemarthrosis; if the synovial fluid analysis shows a synovial RBC count greater than 81,500 and RBC count per HPF greater than 16.3, we recommend immediate interventional angiography rather than continuing conservative treatment.Entities:
Keywords: analysis; angiography; embolization; hemarthrosis; synovial fluid; therapeutic
Year: 2022 PMID: 35454024 PMCID: PMC9025792 DOI: 10.3390/diagnostics12040976
Source DB: PubMed Journal: Diagnostics (Basel) ISSN: 2075-4418
Figure 1Flow chart of study population selection.
Clinical characteristics of 16 patients who were diagnosed with knee hemarthrosis and underwent computed tomography angiography.
| Variables | Group A (n = 14) | Group B (n = 15) | |
|---|---|---|---|
| Mean (range) | |||
| Age (years) | 67.2 (52–85) | 68.5 (51–83) | 0.73 |
| Duration of conservative treatment (months) | 4.3 (2.4–7.5) | 3.9 (2.8–5.1) | 0.21 |
| Number of arthrocentesis procedures | 5.1 (4–6) | 3.3 (3–4) | <0.01 |
| Follow-up period (months) | 22.3 (12.6–38.2) | 21.2 (12.3–50.6) | 0.75 |
| Number | |||
| Sex (female:male) | 8:6 | 6:9 | 0.37 |
| Surgical history | |||
| None (native knee) | 5 | 7 | |
| TKA | 5 | 7 | |
| Revision TKA | 4 | 1 | |
Group A: interventional angiography and selective embolization after failed conservative treatment; Group B: successful results after conservative treatment; TKA, total knee arthroplasty.
Serologic test results and synovial fluid analyses between two groups.
| Variables | Group A (n = 14) | Group B (n = 15) | |
|---|---|---|---|
| Serum | |||
| Hb (g/dL) | 10.3 (5.3–14.9) | 10.7 (6.3–13.9) | 0.66 |
| Hct (%) | 31.0 (16.1–44.3) | 33.1 (18.7–43.1) | 0.45 |
| PT (s) | 12.5 (10.7–14.3) | 11.9 (10.3–13.4) | 0.14 |
| aPTT (s) | 30.9 (24.3–38.8) | 31.7 (24.9–36.7) | 0.57 |
| INR | 1.1 (0.9–1.5) | 1.0 (0.9–1.2) | 0.20 |
| ESR (mm/h) | 12.5 (2–20) | 14.7 (2–24) | 0.37 |
| CRP (mg/dL) | 0.5 (0.1–1.0) | 0.6 (0.1–1.1) | 0.19 |
| Synovial Fluid | |||
| RBC (cells/µL) | 1,905,857 (200,000–4,890,000) | 7730 (15–28,000) | <0.01 |
| WBC (cells/µL) | 1386.5 (4–4500) | 2230.0 (140–4160) | 0.15 |
| Neutrophil (%) | 39.6 (13–52) | 32.6 (10–69) | 0.25 |
| RBC (number/HPF) | 68.9 (25–100) | 3.2 (0.5–25) | <0.01 |
Group A: interventional angiography and selective embolization after failed conservative treatment; Group B: successful results after conservative treatment; Hb, hemoglobin; Hct, hematocrit; PT, prothrombin time; aPTT, activated partial thromboplastin time; INR, international normalized ratio; ESR, erythrocyte sedimentation rate; CRP, C-reactive protein; HPF, high-power field.
Figure 2(A) Values of synovial red blood cells (RBCs) and (B) number of RBCs per high-power field under the smear of the synovial fluid smear. Group A: interventional angiography and selective embolization after failed conservative treatment. Group B: successful results after conservative treatment.
Detailed information on patients who underwent interventional angiography and selective embolization.
| Age (Years)/Sex | Surgical History | Feeding Artery | Findings |
|---|---|---|---|
| 75/Male | TKA | LSGA, DGA | Hypervascularization |
| 59/Male | TKA | LIGA | Hypervascularization, contrast blush |
| 67/Male | TKA | LIGA, anterior tibial recurrent artery, | Contrast blush |
| 53/Male | None | Medial DGA | Hypervascularization |
| 71/Male | None | LIGA, LSGA, Medial DGA | Hypervascularization, contrast blush |
| 52/Male | None | LIGA, LSGA | Hypervascularization |
| 72/Female | Revision TKA | LIGA | Hypervascularization, contrast blush |
| 78/Female | Revision TKA | LSGA, MSGA, muscular artery | Multiple pseudoaneurysm, contrast blush |
| 85/Female | Revision TKA | Medial DGA, anterior tibial recurrent artery | Hypervascularization, contrast blush |
| 74/Female | Revision TKA | Multiple genicular artery | Hypervascularization, contrast blush |
| 75/Male | TKA | Medial DGA, LSGA | Hypervascularization |
| 63/Female | None | Medial DGA | Hypervascularization |
| 60/Male | None | LIGA, LSGA | Hypervascularization |
| 57/Female | TKA | Medial DGA, LIGA | Hypervascularization, contrast blush |
TKA, total knee arthroplasty; LSGA, lateral superior genicular artery; DGA, descending genicular artery; LIGA, lateral inferior genicular artery; MSGA, medial superior genicular artery.